NCT05527782View on ClinicalTrials.gov

Induction Modified TPF Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

August 31, 2025

Study Completion Date

October 31, 2025

Conditions
Locally Advanced Head and Neck Squamous Cell Carcinoma
Interventions
DRUG

modified TPF

modified TPF: modified docetaxel-cisplatin-fluorouracil followed by concurrent chemoradiotherapy

OTHER

Quality of life assessment (QoL)

Quality of life assessment with questionnaires: EORTC QLQ-C30 and QLQ H\&N-35

Trial Locations (3)

46017

Hospital Universitario Doctor Peset, Valencia

46702

Hospital Comarcal Francesc De Borja, Gandia

03570

Hospital Marina Baixa, Villajoyosa

All Listed Sponsors
lead

Hospital Universitario Doctor Peset

OTHER

NCT05527782 - Induction Modified TPF Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | Biotech Hunter | Biotech Hunter